Management of antiphospholipid syndrome

Therapeutic Advances in Musculoskeletal Disease

Volumn 2, Issue 4, 2010, Pages 221-227

  Del Papa, Nicoletta ^a   Vaso, Nikoleta ^a  

^a ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

Author keywords

anti phospholipid antibodies; anti phospholipid syndrome; anti phospholipid therapy

Indexed keywords

EID: 84993820026     PISSN: 1759720X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1759720X10365969     Document Type: Article

References (51)

1. Acog (2005) Antiphospholipid syndrome. Practice Bulletin 68. Obstet Gynecol 106: 1113.
2. Adamson, R., Sangle, S.H., Kaul, A., Hughes, G. and D'Cruz, D. ( 2008) J Clin Rheumatol 14: 359-360.
3. APAS Foundation Writing Committee (2004) Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 291: 576-584.
4. Asherson, R.A., Cervera, R., Piette, J.C., Font, J., Lie, J.T., Burcoglu, A. et al. (1998) Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77: 195-207.
5. Asherson, R.A., Cervera, R., Piette, J.C., Shoenfeld, Y., Espinosa, G., Petri, M.A. et al. (2001) Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80: 355-377.
6. Bates, S.M., Greer, I.A., Pabinger, I., Sofaer, S. and Hirsh, J. ( 2008) Venous thromboembolism, thrombophilia, anthithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 844S.
7. Belmont, H.M. 2000 Catastrophic antiphospholipid syndrome, In: Khamashta, M. (ed.), Hughes Syndrome, Springer-Verlag: London, pp. 127-134.
8. Branch, D.W., Peaceman, A.M., Druzin, M., Silver, R.K., El-Sayed, Y., Silver, R.M. et al. (2000) A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 182: 122-127.
9. Cervera, R., Piette, J.C., Font, J., Khamashta, M.A., Shoenfeld, Y., Camps, M.T. et al. (2002) Antiphospholipid syndrome: Clinical and immunological manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46: 1019-1027.
10. Cowchock, F.S., Reece, E.A., Balaban, D., Branch, D.W. and Plouffe, L. ( 1992) Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low dose heparin treatment. Am J Obstet Gynecol 166: 1318-1323.
11. Crowther, M.A., Ginsberg, J.S., Math, J.J., Denburg, J., Hirsh, J., Douketis, J. et al. (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349: 1133-1138.
12. Edwards, J., Cambridge, G. and Abrahams, V.M. ( 1999) Do self-perpetuating B lymphocytes drive human autoimmune disease? Immunology 97: 188-196.
13. Edwards, M.H., Pierangeli, S., Liu, X., Barker, J.H., Anderson, G. and Harris, E.N. ( 1997) Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation 96: 4380-4384.
14. Empson, M., Lassere, M., Craig, J.C. and Scott, J.R. ( 2002) Recurrent pregnancy loss with antiphospholipid antibody: A systemic review of therapeutic trials. Am J Obstet Gynecol 99: 135-144.
15. Empson, M., Lassere, M., Craig, J. and Scott, J. ( 2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev Apr 18; (2).
16. Erkan, D., Harrison, M.J., Levy, R., Peterson, M., Petri, M., Sammaritano, L. et al. (2007) Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum 56: 2382-2391.
17. Erkan, D., Patel, S., Nuzzo, M., Gerosa, M., Meroni, P.L. and Tincani, A. ( 2008) Management of controversial aspects of antiphospholipid syndrome pregnancies: A guide for clinicians and researchers. Rheumatology 47: iii23-iii27.
18. Erre, G.L., Pardini, S., Faedda, R. and Passiu, G. ( 2008) Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature. Lupus 17: 50-55.
19. Espinola, R.G., Pierangeli, S.S., Ghara, A.E. and Harris, E.N. ( 2002) Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost 87: 518.
20. Farquarson, R.G., Quenby, S. and Greaves, M. ( 2002) Antiphospholipid syndrome in pregnancy: A randomized, controlled trial of treatment. Am J Obstet Gynecol 100: 408-413.
21. Finazzi, G., Marchioli, R., Brancaccio, V., Schinco, P., Wisloff, F., Musial, J. et al. (2005) A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with antiphospholipid syndrome (WAPS). J Thromb Haemost 3: 848-853.
22. Forastiero, R., Martinuzzo, M., Pombo, G., Puente, D., Rossi, A. and Celebrin, L. ( 2005) A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis. J Thromb Hemost 3: 1231-1238.
23. Frampton, G., Cameron, J.S., Thom, M., Jones, S. and Raftery, M. ( 1987) Successful removal of antiphospholipid antibody during pregnancy using plasma exchange and low dose prednisolone. Lancet 2: 1023.
24. Fulcher, D., Stewart, T., Exner, T., Trudinger, B. and Jeremy, R. ( 1989) Plasma exchange and the anticardiolipin syndrome in pregnancy. Lancet 2: 171.
25. Galli, M., Lucani, D., Bertolini, G. and Barbuni, T. ( 2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systemic review of the literature. Blood 101: 1827-1832.
26. Khamashta, M.A., Buchanan, N.M. and Hughes, G.R. ( 1996) The use of hydroxychloroquine in lupus pregnancy: The British experience. Lupus 5: S65-S66.
27. Khamashta, M.A., Cuadrado, M.J., Mujic, F., Taub, N.A., Hunt, B.J. and Hughes, G.R. ( 1995) The management of thrombosis in the antiphospholipid syndrome. N Engl J Med 332: 993-997.
28. Laskin, C.A., Bombardier, C., Hannah, M.E., Mandel, F.P., Ritchie, J.W., Farewell, V. et al. (1997) Prednisone and aspirin in women with antiphospholipid antibodies and unexplained recurrent fetal loss. N Engl J Med 337: 148.
29. Lassere, M. and Empson, M. ( 2004) Treatment of antiphospholipid syndrome in pregnancy - a systematic review of randomized therapeutic trials. Thromb Res 114: 419-426.
30. Levine, J.S., Branch, D.W. and Rauch, J. ( 2002) The antiphospholipid syndrome. N Engl J Med 346: 752-763.
31. Lockshin, M.D., Druzin, M.L. and Qamar, T. ( 1989) Prednisone does not prevent recurrent fetal death in woman with antiphospholipid antibody. Am J Obstet Gynecol 160: 439-443.
32. Lockwood, C.J., Romero, R., Feinberg, R.F., Clyne, L.P., Coster, B. and Hobbins, J.C. ( 1989) The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 161: 369-373.
33. McLaughlin, P., Hagemeister, F. and Grillo-Lopez, A. ( 1999) Rituximab in indolent lymphoma: The single-agent pivotal trial. Semin Oncol 26(Suppl 14): 79-87.
34. Martinez-Berriotxoa, A., Ruiz-Irastorza, G., Egurbide, M.V., Garmendia, M., Gabriel Erdozain, J., Villar, I. et al. (2007) Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erithematosus. Lupus 16: 810-816.
35. Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R. et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306.
36. Motta, M., Tincani, A., Faden, D., Zinzini, E., Lojacono, A., Marchesi, A. et al. (2005) Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol 25: 86-89.
37. Parke, A. and West, B. ( 1996) Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol 23: 1715-1718.
38. Pattison, N.S., Chamley, L.W., Birdsall, M., Zanderigo, A.M., Liddell, H.S. and McDougall, J. ( 2000) Does aspirin have a role in improving pregnancy outcome for women with antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 183: 1008-1012.
39. Pauzner, R., Dulitzki, M., Lanevitz, P., Livneh, A., Kenett, R. and Many, A. ( 2001) Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 86: 1379-1384.
40. Ruiz-Irastorza, G., Hunt, B.J. and Kamashta, M.A. ( 2007) A systemic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheum 57: 1487-1495.
41. Ruiz-Irastorza, G. and Kamashta, M.A. ( 2007) Antiphospholipid syndrome in pregnancy. Rheum Dis Clin North Am 33: 287-297.
42. Scott, J.R., Branch, W.D., Kochenour, N.K. and Ward, K. ( 1988) Intravenous immunoglobulin treatment of patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 159: 1055-1061.
43. Shaw, T., Quan, J. and Tortoritis, M. ( 2003) B cell therapy for rheumatoid arthritis: The rituximab (anti CD20) experience. Ann Rheum Dis 62(Suppl II): ii55-ii59.
44. Silver, R.K., MacGregor, S.N., Sholl, J.S., Hobart, J.M., Neerhof, M.G. and Ragin, A. ( 1993) Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody positive obstetric patients. Am J Obstet Gynecol 169: 1411-1417.
45. Silverman, G. and Weisman, S. ( 2003) Rituximab therapy and autoimmune disorders: Prospects for anti-B cell therapy. Arthritis Rheum Dis 48: 1484-1492.
46. Statkute, L., Traynor, A., Oyama, Y., Yaung, K., Verda, L., Krosnjar, N. et al. (2005) Blood 106: 2700-2709.
47. Tincani, A., Branch, W., Levy, R.A., Piette, J.C., Carp, H., Rai, R.S. et al. (2003) Treatment of pregnant patients with antiphospholipid syndrome. Lupus 12: 524-529.
48. Toubi, E., Kessel, A., Rosner, I., Rozenbaum, M., Lorber, M., Paran, D. et al. (2003) Quinacrine added to ongoing therapeutic regimens attenuates anticardiolipin antibody production in SLE. Lupus 12: 297-301.
49. Triolo, G., Ferrante, A., Ciccia, F., Accardo-Palumbo, A., Perino, A., Castelli, A. et al. (2003) Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 48: 728-731.
50. Tsokos, G. ( 2004) B cell depletion in the treatment of rheumatoid arthritis. N Engl J Med 350: 2546-2548.
51. Tuthill, J.I. and Khamashta, M.A. (2009) Management of antiphospholipid syndrome. J Autoimmun 33: 92-98.